Vir Biotechnology (VIR) Income After Tax (2018 - 2026)
Vir Biotechnology (VIR) recorded Income After Tax of -$96.25 million in Q3 2026, compared with -$163.14 million a year earlier.
Powered by 
Analysis
Vir Biotechnology (VIR) Income After Tax (2018 - 2026) Analysis & Trends
On a TTM basis, Vir Biotechnology's Income After Tax came in at -$184.79 million as of Sep 30, 2026; for FY2025, it came in at -$437.99 million.
- Across earlier years, Income After Tax came in at -$521.96 million in FY2024, -$615.12 million in FY2023, $515.84 million in FY2022 (-2.4%) and $528.58 million in FY2021.
- Quarterly Income After Tax has ranged from -$213.72 million in Q3 2024 to $525.25 million in Q4 2021 over the past five years.
- Per Business Quant, the preceding three quarters came in at $80.08 million (Q2 2026), -$125.7 million (Q1 2026) and -$42.92 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income After Tax (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 6.45 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 210.00 Mn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 4.22 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 5.07 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 4.80 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 3.86 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 2.43 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 3.25 Bn |
| 10 | Vir Biotechnology | 2.23 Bn | 313.19 Mn | 188,000.00 | -96.25 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -96.25 Mn |
| Jun 30, 2026 | 80.08 Mn |
| Mar 31, 2026 | -125.70 Mn |
| Dec 31, 2025 | -42.92 Mn |
| Sep 30, 2025 | -163.14 Mn |
| Jun 30, 2025 | -110.96 Mn |
| Mar 31, 2025 | -120.97 Mn |
| Dec 31, 2024 | -104.59 Mn |
| Sep 30, 2024 | -213.72 Mn |
| Jun 30, 2024 | -138.38 Mn |
| Mar 31, 2024 | -65.28 Mn |
| Dec 31, 2023 | -115.97 Mn |
| Sep 30, 2023 | -163.41 Mn |
| Jun 30, 2023 | -194.78 Mn |
| Mar 31, 2023 | -140.96 Mn |
| Dec 31, 2022 | -101.60 Mn |
| Sep 30, 2022 | 175.31 Mn |
| Jun 30, 2022 | -76.49 Mn |
| Mar 31, 2022 | 518.62 Mn |
| Dec 31, 2021 | 525.25 Mn |
API Access
Vir Biotechnology Income After Tax API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=profit-after-tax&ticker=VIR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "profit-after-tax", "ticker": "VIR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=profit-after-tax&ticker=VIR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();